NRIX
Price
$11.64
Change
+$0.02 (+0.17%)
Updated
Jun 27 closing price
Capitalization
888.14M
12 days until earnings call
STOK
Price
$11.63
Change
-$0.21 (-1.77%)
Updated
Jun 27 closing price
Capitalization
634.42M
44 days until earnings call
Interact to see
Advertisement

NRIX vs STOK

Header iconNRIX vs STOK Comparison
Open Charts NRIX vs STOKBanner chart's image
Nurix Therapeutics
Price$11.64
Change+$0.02 (+0.17%)
Volume$2.06M
Capitalization888.14M
Stoke Therapeutics
Price$11.63
Change-$0.21 (-1.77%)
Volume$1.37M
Capitalization634.42M
NRIX vs STOK Comparison Chart in %
Loading...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRIX vs. STOK commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a StrongBuy and STOK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (NRIX: $11.65 vs. STOK: $11.62)
Brand notoriety: NRIX and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 183% vs. STOK: 192%
Market capitalization -- NRIX: $888.14M vs. STOK: $634.42M
NRIX [@Biotechnology] is valued at $888.14M. STOK’s [@Biotechnology] market capitalization is $634.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 1 FA rating(s) are green whileSTOK’s FA Score has 1 green FA rating(s).

  • NRIX’s FA Score: 1 green, 4 red.
  • STOK’s FA Score: 1 green, 4 red.
According to our system of comparison, STOK is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 5 TA indicator(s) are bullish while STOK’s TA Score has 2 bullish TA indicator(s).

  • NRIX’s TA Score: 5 bullish, 5 bearish.
  • STOK’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than STOK.

Price Growth

NRIX (@Biotechnology) experienced а +1.39% price change this week, while STOK (@Biotechnology) price change was +0.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

NRIX is expected to report earnings on Oct 09, 2025.

STOK is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($888M) has a higher market cap than STOK($634M). STOK YTD gains are higher at: 5.349 vs. NRIX (-38.163). STOK has higher annual earnings (EBITDA): 40.3M vs. NRIX (-214M). NRIX has more cash in the bank: 550M vs. STOK (357M). STOK has less debt than NRIX: STOK (2.35M) vs NRIX (26.6M). STOK has higher revenues than NRIX: STOK (191M) vs NRIX (56.4M).
NRIXSTOKNRIX / STOK
Capitalization888M634M140%
EBITDA-214M40.3M-531%
Gain YTD-38.1635.349-713%
P/E RatioN/A14.17-
Revenue56.4M191M30%
Total Cash550M357M154%
Total Debt26.6M2.35M1,131%
FUNDAMENTALS RATINGS
STOK: Fundamental Ratings
STOK
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
41
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRIXSTOK
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 23 days ago
82%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MOPCX18.530.11
+0.60%
NYLI WMC Small Companies Class C
TIBRX29.910.08
+0.27%
Thornburg Investment Income Builder R3
INDZX17.01N/A
N/A
Columbia Large Cap Value A
AEDNX12.35N/A
N/A
Water Island Event-Driven Fund I
ARYMX13.12N/A
N/A
American Century Global Real Estate A

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+0.26%
KYMR - NRIX
61%
Loosely correlated
-3.48%
IDYA - NRIX
59%
Loosely correlated
-4.04%
DNLI - NRIX
58%
Loosely correlated
-2.77%
RNA - NRIX
56%
Loosely correlated
-2.68%
BEAM - NRIX
55%
Loosely correlated
-2.04%
More